Y-Biologics Inc. logo

Y-Biologics Inc. (338840)

Market Open
11 Aug, 06:30
KRX SM KRX SM
11,280. 00
-90
-0.7916%
480.62B Market Cap
- P/E Ratio
- Div Yield
70,239 Volume
- Eps
11,370
Previous Close
Add Transaction
Day Range
10,870 11,300
Year Range
7,230 38,000
Want to track 338840 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Y-Biologics Inc. (338840) Statistics

Valuation metrics

Market Cap 480.62B
Enterprise value 437.08B
Trailing P/E (ttm) -66.86
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) 127.28
Price/Book (mrq) 31.68
Enterprise Value/Revenue 121.02
Enterprise Value/EBITDA -64.84

Overview

Shares outstanding 14.95M
Float 10.55M
Shares short -
% Held by insiders 0.29%
% Held by institutions 0.01%
Average volume (10 days) 276.53K
Average volume (90 days) 275.65K

Price summary

52-Week low 7,230
52-Week high 38,000
Beta 2.51
50-Day moving average 26,613
200-Day moving average 18,949.15

Financials

Fiscal year

Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Sep 2025

Profitability

Profit margin -2.42%
Operating margin -2.83%

Operational effectiveness

Return on assets -0.14%
Return on equity -0.49%

Income Statement

Revenue (ttm) 3.61B
Revenue per share (ttm) 243.18
Quarterly revenue growth (yoy) -0.72%
Gross profit (ttm) 2.64B
EBITDA -6.74B
Net income to common (ttm) -8.73B
Diluted EPS (ttm) -511
Quarterly earnings growth (yoy) -0.72%

Balance Sheet

Total cash (mrq) 42.27B
Total cash per share (mrq) 2,824.56
Total debt (mrq) 19.15B
Total Debt/Equity (mrq) 139.03
Current ratio (mrq) 1.16%
Book value per share (mrq) 920.23

Cash Flow

Cash flow statement -5.26B
Levered free cash flow (LFCF) 12.48B